Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience

J Endocrinol Invest. 2021 Dec;44(12):2849-2851. doi: 10.1007/s40618-021-01604-6. Epub 2021 May 30.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones* / classification
  • Adrenal Cortex Hormones* / pharmacology
  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment
  • Drug Interactions*
  • Drug-Related Side Effects and Adverse Reactions* / diagnosis
  • Drug-Related Side Effects and Adverse Reactions* / epidemiology
  • Drug-Related Side Effects and Adverse Reactions* / etiology
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Italy / epidemiology
  • Male
  • Multiple Chronic Conditions* / drug therapy
  • Multiple Chronic Conditions* / epidemiology
  • Pharmaceutical Preparations / classification*
  • Pharmacokinetics
  • Polypharmacology*
  • Retrospective Studies
  • Risk Adjustment / methods*
  • Risk Assessment
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Pharmaceutical Preparations